Valuation: ORIENT BIO Inc.

Market Cap 110B 160,165B 96.33B 89.58B 82.2B 154B 10,562B 157B 1,064B 416B 5,193B 412B 403B 17,953B P/E 2020
-5.36x
P/E 2021 -11.4x
Enterprise Value 106B 154,859B 93.14B 86.62B 79.48B 149B 10,212B 152B 1,029B 402B 5,021B 398B 390B 17,359B EV / Sales 2020
1.66x
EV / Sales 2021 3.53x
Free-Float
64.38%
Yield 2020 *
-
Yield 2021 -
07-08 Orient Precision Industries Inc announced that it has received KRW 2.8975 billion in funding from ORIENT BIO Inc. CI
06-22 Orient Precision Industries Inc announced that it expects to receive KRW 2.8975 billion in funding from ORIENT BIO Inc. CI
02-22 Orient Precision Industries Inc announced that it has received KRW 3.138 billion in funding from ORIENT BIO Inc. CI
02-09 Orient Precision Industries Inc announced that it expects to receive KRW 3.138 billion in funding from ORIENT BIO Inc. CI
12-02 Orient Bio to sell 9.4 billion won of own shares RE
25-08-11 Alerts on CEO and chairman appointment wrongly tagged to Orient Bio withdrawn RE
22-12-15 Pregen Inc. announced that it has received KRW 1.7 billion in funding from Orient Co.,Ltd, ORIENT BIO Inc., ORIENT WATCH CO.,LTD. CI
22-11-30 Pregen Inc. announced that it expects to receive KRW 1.7 billion in funding from Orient Co.,Ltd, ORIENT BIO Inc., ORIENT WATCH CO.,LTD. and other investors CI
22-08-09 Orient Electronics Co.,Ltd. announced that it has received KRW 3.049998525 billion in funding from Orient Precision Industries Inc, ORIENT BIO Inc. CI
22-07-19 Orient Electronics Co.,Ltd. announced that it expects to receive KRW 3.049998525 billion in funding from Orient Precision Industries Inc, ORIENT BIO Inc. CI
22-02-14 ORIENT BIO Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
22-01-26 Inotiv, Inc. acquired Orient BioResource Center, Inc. from ORIENT BIO Inc. for $51.3 million. CI
21-11-14 ORIENT BIO Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
1 week+10.73%
Current month+10.73%
1 month+17.51%
3 months-12.03%
6 months-12.81%
Current year-18.47%
1 week 840
Extreme 840
1,172
1 month 788
Extreme 788
1,172
Current year 745
Extreme 745
1,632
1 year 745
Extreme 745
1,632
3 years 745
Extreme 745
5,120
5 years 745
Extreme 745
5,120
10 years 745
Extreme 745
10,799.27
Manager TitleAgeSince
Chief Executive Officer 65 2010-10-04
Corporate Officer/Principal 36 2024-06-27
Corporate Officer/Principal 49 -
Director TitleAgeSince
Chairman 65 2010-10-04
Director/Board Member 61 2003-06-30
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+10.73%-28.05%-19.80% 39.78M
+0.93%+6.97%+59.60%+69.78% 57.28B
-1.92%+6.03%+40.64%+80.66% 54.99B
-0.46%-1.29%+2.86%+425.15% 23.18B
-2.97%-2.35%-22.53%-15.34% 22.59B
-0.36%+5.73%+24.13%-7.02% 20.46B
-1.34%+0.51%+26.03%-28.68% 17.56B
-1.44%+5.67%+38.77%+565.80% 15.67B
-1.30%-5.02%+170.77%+310.94% 14.46B
-0.50%-0.98%+21.43%+179.36% 13.92B
Average -0.94%+2.01%+33.36%+156.09% 24.01B
Weighted average by Cap. -0.87%+2.10%+39.69%+138.04%

Financials

2020 2021
Net sales 37.7B 55,054B 33.11B 30.79B 28.26B 53.09B 3,630B 53.91B 366B 143B 1,785B 142B 138B 6,171B 52.02B 75,968B 45.69B 42.49B 38.99B 73.26B 5,010B 74.39B 505B 197B 2,463B 195B 191B 8,516B
Net income -10.88B -15,890B -9.56B -8.89B -8.16B -15.32B -1,048B -15.56B -106B -41.23B -515B -40.85B -39.97B -1,781B -15.63B -22,830B -13.73B -12.77B -11.72B -22.02B -1,506B -22.36B -152B -59.24B -740B -58.69B -57.42B -2,559B
Net Debt 4.07B 5,939B 3.57B 3.32B 3.05B 5.73B 392B 5.82B 39.44B 15.41B 193B 15.27B 14.94B 666B -3.63B -5,306B -3.19B -2.97B -2.72B -5.12B -350B -5.2B -35.24B -13.77B -172B -13.64B -13.35B -595B
Logo ORIENT BIO Inc.
Orient Bio Inc is a Korea-based company engaged in the biotechnology area. The Company produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. It also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.
Employees
125
Date Price Change Volume
26-07-24 ₩980.00 0.00% 664,698
26-07-23 ₩980.00 -0.61% 102,601
26-07-22 ₩986.00 -6.98% 379,623
26-07-21 ₩1,060.00 +17.52% 4,376,650
  1. Stock Market
  2. Stocks
  3. A002630 Stock